194 related articles for article (PubMed ID: 31823769)
41. Protein kinase Cθ controls type 2 innate lymphoid cell and T
Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
[TBL] [Abstract][Full Text] [Related]
42. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
[TBL] [Abstract][Full Text] [Related]
43. YKL-40 promotes the progress of atherosclerosis independent of lipid metabolism in apolipoprotein E
Chen L; Zheng J; Xue Q; Zhao Y
Heart Vessels; 2019 Nov; 34(11):1874-1881. PubMed ID: 31114961
[TBL] [Abstract][Full Text] [Related]
44. Dickkopf-3 Ablation Attenuates the Development of Atherosclerosis in ApoE-Deficient Mice.
Cheng WL; Yang Y; Zhang XJ; Guo J; Gong J; Gong FH; She ZG; Huang Z; Xia H; Li H
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219919
[TBL] [Abstract][Full Text] [Related]
45. Peperomin E (PepE) protects against high fat diet-induced atherosclerosis in Apolipoprotein E deficient (ApoE
Yan J; Li M; Wang XD; Lu ZY; Ni XL
Biomed Pharmacother; 2018 Sep; 105():862-869. PubMed ID: 30021379
[TBL] [Abstract][Full Text] [Related]
46. T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice.
Li BWS; de Bruijn MJW; Lukkes M; van Nimwegen M; Bergen IM; KleinJan A; GeurtsvanKessel CH; Andeweg A; Rimmelzwaan GF; Hendriks RW
Eur J Immunol; 2019 Jan; 49(1):144-156. PubMed ID: 29762870
[TBL] [Abstract][Full Text] [Related]
47. Female and male mouse lung group 2 innate lymphoid cells differ in gene expression profiles and cytokine production.
Mathä L; Shim H; Steer CA; Yin YH; Martinez-Gonzalez I; Takei F
PLoS One; 2019; 14(3):e0214286. PubMed ID: 30913260
[TBL] [Abstract][Full Text] [Related]
48. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
49. Tollip Deficiency Alters Atherosclerosis and Steatosis by Disrupting Lipophagy.
Chen K; Yuan R; Zhang Y; Geng S; Li L
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28396568
[TBL] [Abstract][Full Text] [Related]
50. The IL-25/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice.
Bahhar I; Eş Z; Köse O; Turna A; Günlüoğlu MZ; Çakır A; Duralı D; Magnusson FC
Front Immunol; 2023; 14():1244437. PubMed ID: 37781372
[TBL] [Abstract][Full Text] [Related]
51. Anti-ST2 Nanoparticle Alleviates Lung Inflammation by Targeting ILC2s-CD4
Wu Y; Shi W; Wang H; Yue J; Mao Y; Zhou W; Kong X; Guo Q; Zhang L; Xu P; Wang Y
Int J Nanomedicine; 2020; 15():9745-9758. PubMed ID: 33299314
[TBL] [Abstract][Full Text] [Related]
52. Voluntary Exercise Stabilizes Established Angiotensin II-Dependent Atherosclerosis in Mice through Systemic Anti-Inflammatory Effects.
Pellegrin M; Aubert JF; Bouzourène K; Amstutz C; Mazzolai L
PLoS One; 2015; 10(11):e0143536. PubMed ID: 26600018
[TBL] [Abstract][Full Text] [Related]
53. CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice.
Wang XQ; Wan HQ; Wei XJ; Zhang Y; Qu P
Mol Med Rep; 2016 Jul; 14(1):49-56. PubMed ID: 27176130
[TBL] [Abstract][Full Text] [Related]
54. Anti-TIM-1 Monoclonal Antibody (RMT1-10) Attenuates Atherosclerosis By Expanding IgM-producing B1a Cells.
Hosseini H; Yi L; Kanellakis P; Cao A; Tay C; Peter K; Bobik A; Toh BH; Kyaw T
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29936416
[TBL] [Abstract][Full Text] [Related]
55. Training-induced anti-atherosclerotic effects are associated with increased vascular PPARgamma expression in apolipoprotein E-deficient mice.
Szostak J; Miguet-Alfonsi C; Berthelot A; Laurant P
Acta Physiol (Oxf); 2016 Feb; 216(2):221-30. PubMed ID: 26467845
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice.
Xie W; Li L; Zhang M; Cheng HP; Gong D; Lv YC; Yao F; He PP; Ouyang XP; Lan G; Liu D; Zhao ZW; Tan YL; Zheng XL; Yin WD; Tang CK
PLoS One; 2016; 11(6):e0157085. PubMed ID: 27257686
[TBL] [Abstract][Full Text] [Related]
58. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.
Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z
Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775
[TBL] [Abstract][Full Text] [Related]
59. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
[TBL] [Abstract][Full Text] [Related]
60. PSRC1 overexpression attenuates atherosclerosis progression in apoE
Guo K; Hu L; Xi D; Zhao J; Liu J; Luo T; Ma Y; Lai W; Guo Z
J Mol Cell Cardiol; 2018 Mar; 116():69-80. PubMed ID: 29378206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
